Leading CAR-T Company Broadens Treatment Pipeline

TC BioPharm will collaborate with Scotia Biologics to develop proprietary CAR-T treatments for cancer and anti-viral indications. First CAR-T products will target solid tumours(PRWeb May 07, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15468263.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news